转移性实体恶性肿瘤的临床试验
总计15643个结果
-
Turning Point Therapeutics, Inc.撤销
-
Hanmi Pharmaceutical Company Limited主动,不招人
-
National Cancer Institute (NCI)招聘中
-
National Cancer Institute (NCI)主动,不招人晚期恶性实体瘤 | 不可切除的恶性实体肿瘤 | 转移性恶性实体瘤美国
-
National Cancer Institute (NCI)完全的
-
Memorial Sloan Kettering Cancer Center主动,不招人
-
Jiangsu vcare pharmaceutical technology co., LTD招聘中
-
Ohio State University Comprehensive Cancer Center招聘中
-
iOMEDICO AGBristol-Myers Squibb; Roche Pharma AG完全的
-
Northwestern UniversityGenentech, Inc.完全的未明确的成人实体瘤,特定方案 | 转移癌美国
-
Eli Lilly and CompanyNational Cancer Institute (NCI)完全的
-
Vion Pharmaceuticals完全的
-
Northwestern UniversityNational Cancer Institute (NCI)完全的
-
Virginia Commonwealth UniversityNational Cancer Institute (NCI)完全的
-
Asan Medical CenterKorean Cancer Study Group; Boryung Pharmaceutical Co., Ltd招聘中
-
National Cancer Institute (NCI)招聘中
-
University of California, San Francisco完全的
-
National Cancer Institute (NCI)招聘中
-
National Cancer Institute (NCI)暂停
-
Ronald LevyBristol-Myers Squibb完全的
-
Shenzhen Ionova Life Sciences Co., Ltd.Merck Sharp & Dohme LLC招聘中癌症 | 实体瘤,成人 | 实体癌 | 实体瘤,未指定,成人 | 癌症转移 | 肿瘤,实体美国
-
National Cancer Institute (NCI)主动,不招人晚期恶性实体瘤 | 难治性恶性实体瘤 | 不可切除的恶性实体肿瘤 | 转移性恶性实体瘤美国
-
American College of Radiology Imaging NetworkNational Cancer Institute (NCI)完全的
-
PfizerKyowa Kirin Co., Ltd.终止
-
Nerviano Medical Sciences终止
-
Accelerated Community Oncology Research NetworkGlaxoSmithKline; Genentech, Inc.完全的
-
Sunshine Guojian Pharmaceutical (Shanghai) Co.,...招聘中
-
M.D. Anderson Cancer Center主动,不招人
-
Symphogen A/S主动,不招人
-
Southwest Oncology GroupNational Cancer Institute (NCI)完全的